Home/Filings/4/0001437749-24-012643
4//SEC Filing

Kupiec James William 4

Accession 0001437749-24-012643

CIK 0001069530other

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 9:19 AM ET

Size

9.2 KB

Accession

0001437749-24-012643

Insider Transaction Report

Form 4
Period: 2024-04-18
Kupiec James William
Chief Clinical Dev. Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-18$22.00/sh+1,500$33,0004,000 total
  • Award

    Common Stock Warrant

    2024-01-03+1,0001,000 total
    Exercise: $33.00From: 2024-01-03Exp: 2024-05-07Common Stock (1,500 underlying)
  • Exercise/Conversion

    Common Stock Warrant

    2024-04-181,0000 total
    Exercise: $33.00From: 2024-01-03Exp: 2024-05-07Common Stock (1,500 underlying)
Footnotes (2)
  • [F1]Represents warrants that were originally issued on January 3, 2024 as a distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.
  • [F2]Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Issuer

CASSAVA SCIENCES INC

CIK 0001069530

Entity typeother

Related Parties

1
  • filerCIK 0001839551

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 9:19 AM ET
Size
9.2 KB